| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0cded12770caf61109a49baf7f16880c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28cecfc87bfdb41e74447f4815647949
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43e1bbcd7fe04ec654f5a53e094461ac |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4747 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2004-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fcafd6f09cb228518d29d6739e92a26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4a84c4435745f2c2de4b256db99ba88 |
| publicationDate |
2005-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005014637-A1 |
| titleOfInvention |
Apoptosis inhibitors |
| abstract |
Ezrin mutated at the CD95 binding site reduces CD95-mediated apoptosis and controls metastasis and aggressiveness in tumor cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011036211-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9127077-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009103312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009103319-A3 |
| priorityDate |
2003-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |